Nanologica AB

Nanologica is a Swedish nanotechnology company, world-leading in the development of nanoporous silica particles for purification by chromatography. A proprietary production method enables the company to create supreme products by precisely controlling the shape, size, porosity, and surface properties of silica particles. Nanologica provides products of high-quality silica used in the purification of peptide drugs such as insulin and GLP-1 analogues. These products can contribute to lower costs and increase productivity for pharmaceutical manufacturers, which can increase the availability of cost-effective medicines and give more people around the world access to vital treatment for diabetes and obesity. Nanologica is headquartered...

Chromatography,silica,hplc,nanomaterials,separation,chemistry,purification,insulin purification,peptides,prep,bulk silica,method development,purification media,and preparative chromatography

Nanologica ab operates in the Biotechnology research industry.

Nanologica ab's revenue is 1m - 10m

Nanologica ab has 11 - 50 employees.